Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 96%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,459
Total Claims
$812K
Drug Cost
495
Beneficiaries
$1,640
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+8%
Opioid rate vs peers
2.8% vs 2.6% avg
+54%
Cost per patient vs peers
$1,640 vs $1,068 avg
-11%
Brand preference vs peers
8.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.8%
Opioid Rate
292
Opioid Claims
$3,956
Opioid Cost
4.1%
Long-Acting Rate
Brand vs Generic
Brand: 832 claims · $550K
Generic: 9,527 claims · $258K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Mirabegron | 108 | $48K |
| Iloperidone | 14 | $42K |
| Dulaglutide | 15 | $34K |
| Semaglutide | 21 | $30K |
| Apixaban | 31 | $25K |
| Leuprolide Acetate | 11 | $23K |
| Dapagliflozin Propanediol | 26 | $20K |
| Sitagliptin Phos/Metformin Hcl | 13 | $18K |
| Rivaroxaban | 20 | $17K |
| Insulin Glargine/Lixisenatide | 13 | $17K |
| Aripiprazole | 123 | $16K |
| Insulin Nph Hum/Reg Insulin Hm | 26 | $12K |
| Budesonide/Formoterol Fumarate | 20 | $11K |
| Lurasidone Hcl | 14 | $11K |
| Divalproex Sodium | 97 | $9,940 |
Prescribing Profile
Patient Profile
70
Avg Age
55%
Female
1.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About